PixarBio has scrapped its bid to buy InVivo Therapeutics “for reasons related to management credibility and competence, corporate governance and IP control.”

Researchers at the University of Washington have developed a novel computational method that they believe can be used to determine the influence of individual…

The FDA released a pair of draft guidances giving recommendations on how drug and device makers should communicate information about their products.

Just months after writing off a cholesterol drug, Catabasis is back with the first data on its Duchenne muscular dystrophy candidate.

Pfizer has become the latest Big Pharma company to join a consortium that matches drugmakers to researchers in Cambridge, U.K.

Global pharma chief Hussain joins a long list of departing execs at GSK, Merrimack taps Sanofi Genzyme SVP Dr. Richard Peters as CEO, and ex-GSK rare disease…

An international team may have found an alternative approach to managing peripheral neuropathy that could potentially reverse symptoms with a class of drugs…

Immunomedics says new data for lead drug IMMU-132 in triple-negative breast cancer keep it on course to file for accelerated approval in mid-2017.